fbpx

Good for blood pressure…Not so good for eyes

 

High blood pressure drugs may increase the risk of age-related macular degeneration.

 

Researchers from the University of Wisconsin conducted a long-term study between 1988 and 2013 involving 5,000 residents of Beaver Dam, aged 43 to 86 years. They found that using any vasodilator (such as Apresoline or Loniten) was associated with a 72% greater risk of developing early-stage AMD. An estimated 8.2% of the people who were not taking vasodilators developed AMD symptoms, compared to 19.1% of those who were.

 

A similar increase (+71%) in the risk of neovascular AMD was found in people using oral beta blockers such as Tenormin and Lopressor. An estimated 0.5% of non-users developed this form of the condition, compared to 1.2% of users.

 

While the study provides risk estimates of associations between blood pressure lowering medications and AMD at various stages, it was not able to provide any direct indication of the effects of the medications themselves or the conditions for which participants were taking the medications. “It is important that these results be replicated and tested in a clinical trials setting before changing anyone’s medication regimens,” cautioned lead researcher Dr. Ronald Klein.


Source:

http://www.aao.org/newsroom/release/blood-pressure-drugs-may-be-associated-with-AMD.cfm

 

Featured Posts

Empower your Practice With Data

EMPOWER Your Practice Series Launches with Strong Attendance and Practical Insights

Eye Care Business Canada, in collaboration with the Clinical & Refractive Optometry (CRO) Journal, officially launched its three-part CE series EMPOWER Your Practice on April 9 with the first webinar, The Digital Journey: Using Data to Drive Practice Growth & Patient Care.

Read more
EssilorLuxottica Oliver Peoples 2025 logo

EssilorLuxottica and Roger Federer Extend Exclusive Global Eyewear Collaboration Between the RF Brand and Oliver Peoples

EssilorLuxottica and Roger Federer announce the renewal of their successful collaboration for the design, manufacture and worldwide distribution of eyewear under the Roger Federer (“RF”) and Oliver Peoples brands.

Read more
Fighting Blindness Canada research

Gene Editing Therapy to be Tested for Treatment of Wet AMD

A phase 1 clinical trial will be launching soon to test a gene editing approach for wet age-related macular degeneration (wet AMD).

Read more
Voila March-April Optik 2025 WestGroupe OTPS OTPS2046

OTP Embraces a Bold, Edgy Look for Sunny Days!

OTPS-2046 combines a trendy racer-type design with a modified cat-eye shape, boasting a curved base for a close, comfortable fit.

Read more
World Council of Optometry

World Council of Optometry Announces 2025 International Award Winners

The WCO announces the recipients of its prestigious international awards, recognizing individuals for their exceptional contributions to advancing optometry worldwide.

Read more
Empower your Practice With Data

EMPOWER Your Practice Series Launches with Strong Attendance and Practical Insights

Eye Care Business Canada, in collaboration with the Clinical & Refractive Optometry (CRO) Journal, officially launched its three-part CE series EMPOWER Your Practice on April 9 with the first webinar, The Digital Journey: Using Data to Drive Practice Growth & Patient Care.

Read more
EssilorLuxottica Oliver Peoples 2025 logo

EssilorLuxottica and Roger Federer Extend Exclusive Global Eyewear Collaboration Between the RF Brand and Oliver Peoples

EssilorLuxottica and Roger Federer announce the renewal of their successful collaboration for the design, manufacture and worldwide distribution of eyewear under the Roger Federer (“RF”) and Oliver Peoples brands.

Read more
Fighting Blindness Canada research

Gene Editing Therapy to be Tested for Treatment of Wet AMD

A phase 1 clinical trial will be launching soon to test a gene editing approach for wet age-related macular degeneration (wet AMD).

Read more
Voila March-April Optik 2025 WestGroupe OTPS OTPS2046

OTP Embraces a Bold, Edgy Look for Sunny Days!

OTPS-2046 combines a trendy racer-type design with a modified cat-eye shape, boasting a curved base for a close, comfortable fit.

Read more
World Council of Optometry

World Council of Optometry Announces 2025 International Award Winners

The WCO announces the recipients of its prestigious international awards, recognizing individuals for their exceptional contributions to advancing optometry worldwide.

Read more
Empower your Practice With Data

EMPOWER Your Practice Series Launches with Strong Attendance and Practical Insights

Eye Care Business Canada, in collaboration with the Clinical & Refractive Optometry (CRO) Journal, officially launched its three-part CE series EMPOWER Your Practice on April 9 with the first webinar, The Digital Journey: Using Data to Drive Practice Growth & Patient Care.

Read more
EssilorLuxottica Oliver Peoples 2025 logo

EssilorLuxottica and Roger Federer Extend Exclusive Global Eyewear Collaboration Between the RF Brand and Oliver Peoples

EssilorLuxottica and Roger Federer announce the renewal of their successful collaboration for the design, manufacture and worldwide distribution of eyewear under the Roger Federer (“RF”) and Oliver Peoples brands.

Read more
Fighting Blindness Canada research

Gene Editing Therapy to be Tested for Treatment of Wet AMD

A phase 1 clinical trial will be launching soon to test a gene editing approach for wet age-related macular degeneration (wet AMD).

Read more
Voila March-April Optik 2025 WestGroupe OTPS OTPS2046

OTP Embraces a Bold, Edgy Look for Sunny Days!

OTPS-2046 combines a trendy racer-type design with a modified cat-eye shape, boasting a curved base for a close, comfortable fit.

Read more
World Council of Optometry

World Council of Optometry Announces 2025 International Award Winners

The WCO announces the recipients of its prestigious international awards, recognizing individuals for their exceptional contributions to advancing optometry worldwide.

Read more
Empower your Practice With Data

EMPOWER Your Practice Series Launches with Strong Attendance and Practical Insights

Eye Care Business Canada, in collaboration with the Clinical & Refractive Optometry (CRO) Journal, officially launched its three-part CE series EMPOWER Your Practice on April 9 with the first webinar, The Digital Journey: Using Data to Drive Practice Growth & Patient Care.

Read more
EssilorLuxottica Oliver Peoples 2025 logo

EssilorLuxottica and Roger Federer Extend Exclusive Global Eyewear Collaboration Between the RF Brand and Oliver Peoples

EssilorLuxottica and Roger Federer announce the renewal of their successful collaboration for the design, manufacture and worldwide distribution of eyewear under the Roger Federer (“RF”) and Oliver Peoples brands.

Read more
Fighting Blindness Canada research

Gene Editing Therapy to be Tested for Treatment of Wet AMD

A phase 1 clinical trial will be launching soon to test a gene editing approach for wet age-related macular degeneration (wet AMD).

Read more
Voila March-April Optik 2025 WestGroupe OTPS OTPS2046

OTP Embraces a Bold, Edgy Look for Sunny Days!

OTPS-2046 combines a trendy racer-type design with a modified cat-eye shape, boasting a curved base for a close, comfortable fit.

Read more
World Council of Optometry

World Council of Optometry Announces 2025 International Award Winners

The WCO announces the recipients of its prestigious international awards, recognizing individuals for their exceptional contributions to advancing optometry worldwide.

Read more